RecallRadar

FDA Drug recall D-0619-2025

chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100-count bottles Rx only, Manufactured by: Amneal Pharmaceuticals Pvt

On 2025-09-10 the FDA classified a Class II recall of chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100-count bottles Rx only, Manufactured by: Amneal Pharmaceuticals Pvt by Amneal Pharmaceuticals, citing presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detecte….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0619-2025
ClassificationClass II
Statusongoing
Initiated2025-08-18
Published2025-09-10
Last updated2026-09-13 11:52 UTC
CompanyAmneal Pharmaceuticals
DistributionUS

Product

chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100-count bottles Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1062-1.

Reason

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Identifiers

ndc69238-1054-1
ndc69238-1056-1
ndc69238-1058-1
ndc69238-1060-1
ndc69238-1062-1
code_infoLot: AM240336, AM240337, Exp Date 02/28/2027.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0619-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.